0% found this document useful (0 votes)
28 views18 pages

PCOS

Pcos

Uploaded by

samone.jones99
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
28 views18 pages

PCOS

Pcos

Uploaded by

samone.jones99
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 18

PCOS

OBJECTIVES
Define Identify List
Define PCOS.
Discuss potential List most
Discuss clinical
long-term common
presentation of
consequences. treatment
PCOS and define
approaches for
diagnostic
PCOS
criteria.
DEFINITION

Polycystic ovarian syndrome (PCOS) is a


hyperandrogenic state with oligo-
anovulation that any other disorder
cannot explain.

It is a diagnosis of exclusion.
ROTTERDAM
CRITERIA
PCOS is the most common hormonal
disorder in females of reproductive age
worldwide (5-15%).
It is characterized by two out of three of
the following:
1. Chronic Oligo-anovulation
2. Clinical or biochemical
hyperandrogenism
3. Polycystic ovaries.
ETIOLOGY
Genes

70% heritability

Environment
Obesity
Insulin resistance
PATHOPHYSIOLOGY
• Insulin excess, known to sensitize the ovary to luteinizing hormone
(LH).
• Theca cells in PCOS have overexpression of most steroidogenic
enzymes and proteins involved in androgen synthesis, including
P450c17, which has been highly identified.
• Granulosa cells prematurely luteinize primarily as a result of
androgen and insulin excess.
• Androgen excess enhances the initial recruitment of primordial
follicles into the growth pool. Simultaneously, it initiates premature
luteinization and impairs the dominant follicle selection.
HISTORY AND
PHYSICAL
A complete history and physical exam
are critical for the diagnosis of PCOS.
Two out of 3 diagnostic criteria rely on
history and physical exam.
Remember, PCOS is a diagnosis of
exclusion, and identifying the clinical
presentation of other conditions should
be done.
DDX
1.Thyroid disease
2.Hyperprolactinemia
3.Non-classical congenital adrenal hyperplasia.
CHRONIC ANOVULATON

Normal Anovulatory If unclear hx


menstrual cycle dx by history -Serum day 21
21-35 days progesterone or Luteal
<10 menses per year progesterone
3-7 days
to no cycles in a nL >10 ng/ml
moderate
month -Urine ovulation sticks (LH
Regular and
sticks)
recurring >35 days
-LH Peak should occur 1-
1.5 days before ovulation
POLYCYSTIC OVARIES
ASOCIATION
• Infertility
• Endometrial Cancer
• Obesity
• Metabolic disorder
• Insulin resistance/Type 2 diabetes

• Cardiovascular disease
• HTN
• Hyperlipidemia
• NFLD/NASH
• Depression
MANAGEMENT
• Exercise and calorie-restrictive diets are the best first-line
interventions for weight loss and impaired glucose tolerance (IGT)
• Hormonal Contraceptive for menstrual abnormalities, hirsutism,
and acne. The progestin component decreases LH levels,
indirectly decreasing ovarian androgen production.
• Metformin for PCOS patients with DM2 or IGT who fail lifestyle
modifications.
• Clomiphene citrate for infertility. Infertility needs a thorough
history (1 year of attempted fertility when under 35, 6 months
after 35 y/o).
• Letrozole blocks androgen to estrogen conversion, specific
indication in obese women with PCOS undergoing infertility
• Spironolactone for hyperandrogenism
• Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic Ovarian Disease. [Updated 2022 Nov
15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
https://www.ncbi.nlm.nih.gov/books/NBK459251/

• Helena J Teede, Chau Thien Tay, Joop J E Laven, Anuja Dokras, Lisa J Moran, Terhi T Piltonen,
Michael F Costello, Jacky Boivin, Leanne M Redman, Jacqueline A Boyle, Robert J Norman,
Aya Mousa, Anju E Joham, the International PCOS Network , Recommendations from the
2023 international evidence-based guideline for the assessment and management of
polycystic ovary syndrome, European Journal of Endocrinology, Volume 189, Issue 2, August
2023, Pages G43–G64, https://doi.org/10.1093/ejendo/lvad096

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy